Monday, September 14, 2026

Why Anthropic Calls for a Global Pause on AI Development: The Risks of Recursive Self-Improvement

Anthropic calls for a global pause on advanced AI development to address risks of autonomous self-improvement amid competitive pressures.

TRUST ME, I’m an Expert: Trump’s Tylenol-Autism Claim Exposes Washington’s Dangerous NEW Brand of Idiocy

Trump claims Tylenol during pregnancy may raise autism risk, but medical experts refute this as unsupported by scientific evidence.

CJ CheilJedang’s Bibigo Sticky White Rice: How the Sticks To Anything Campaign is Redefining Asian Cuisine in the U.S.

CJ CheilJedang expands global marketing for bibigo Sticky White Rice in the U.S. with the Sticks To Anything campaign.

Tag: Dupixent

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

GI Innovation Uses AI to Develop Next-Gen Allergy Drug Aimed at Dupixent’s $15 Billion Market

GI Innovation is advancing an AI-optimized allergy treatment, targeting multiple pathways in atopic dermatitis to rival Dupixent.

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.